Hopkinson Craig C. insider trades
Hopkinson Craig C. has filed 41 Form 4s with the SEC that we hold, for Alkermes plc. (ALKS) (EVP R&D, Chief Medical Officer) and ALBO (Director). Across all of them we count 0 purchases worth $0 and 28 sales worth $24.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 15 sales ($3.7M). The largest single trade was a sale of 171,813 shares of Alkermes plc. worth $5.6M, dated 2025-02-12. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-16 and the latest 2026-09-01.
Alkermes plc. (ALKS)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-02-18 | S, sale reported on Form 4 | 2,306 | $58.0K | 2022-02-23 | SEC |
| 2022-02-23 | S, sale reported on Form 4 | 11,983 | $296.7K | 2022-02-24 | SEC |
| 2024-11-06 | S, sale reported on Form 4 | 10,471 | $309.2K | 2024-11-06 | SEC |
| 2024-11-11 | S, sale reported on Form 4 | 58,996 | $1.8M | 2024-11-12 | SEC |
| 2024-12-04 | S, sale reported on Form 4 | 14,349 | $441.5K | 2024-12-04 | SEC |
| 2024-12-05 | S, sale reported on Form 4 | 9,221 | $290.5K | 2024-12-05 | SEC |
| 2024-12-09 | S, sale reported on Form 4 | 61,151 | $2.0M | 2024-12-09 | SEC |
| 2025-01-30 | S, sale reported on Form 4 | 100,918 | $3.2M | 2025-01-31 | SEC |
| 2025-02-12 | S, sale reported on Form 4 | 171,813 | $5.6M | 2025-02-14 | SEC |
| 2025-02-12 | S, sale reported on Form 4 | 33,108 | $1.1M | 2025-02-14 | SEC |
| 2025-02-13 | S, sale reported on Form 4 | 108,833 | $3.9M | 2025-02-14 | SEC |
| 2025-02-13 | S, sale reported on Form 4 | 35,586 | $1.2M | 2025-02-14 | SEC |
| 2025-10-15 | S, sale reported on Form 4 | 9,000 | $283.8K | 2025-10-15 | SEC |
| 2025-11-03 | S, sale reported on Form 4 | 9,000 | $273.4K | 2025-11-03 | SEC |
| 2025-12-01 | S, sale reported on Form 4 | 4,000 | $117.2K | 2025-12-01 | SEC |
| 2025-12-03 | S, sale reported on Form 4 | 3,748 | $112.4K | 2025-12-05 | SEC |
| 2026-01-02 | S, sale reported on Form 4 | 4,000 | $112.0K | 2026-01-02 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 5,000 | $150.0K | 2026-01-08 | SEC |
| 2026-02-02 | S, sale reported on Form 4 | 5,000 | $171.2K | 2026-02-02 | SEC |
| 2026-02-02 | S, sale reported on Form 4 | 4,000 | $134.2K | 2026-02-02 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 9,000 | $267.5K | 2026-03-04 | SEC |
| 2026-04-01 | S, sale reported on Form 4 | 9,000 | $319.6K | 2026-04-01 | SEC |
| 2026-05-01 | S, sale reported on Form 4 | 9,000 | $300.6K | 2026-05-01 | SEC |
| 2026-06-01 | S, sale reported on Form 4 | 9,000 | $375.0K | 2026-06-01 | SEC |
| 2026-07-01 | S, sale reported on Form 4 | 8,300 | $427.1K | 2026-07-01 | SEC |
| 2026-07-01 | S, sale reported on Form 4 | 700 | $36.5K | 2026-07-01 | SEC |
| 2026-08-03 | S, sale reported on Form 4 | 9,000 | $437.2K | 2026-08-03 | SEC |
| 2026-09-01 | S, sale reported on Form 4 | 9,000 | $422.9K | 2026-09-01 | SEC |
ALBO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1730048) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
